CLRO vs SYNA vs MTSI vs AMBA

For growth investors, MACOM Technology Solutions Holdings, Inc.

(MTSI) is the stronger pick with 32. 6% revenue growth year-over-year, versus -39. 1% for ClearOne, Inc. (CLRO). Analysts rate ClearOne, Inc. (CLRO) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, MACOM Technology Solutions Holdings, Inc.

(MTSI) delivered a total return of +513. 6%, compared to -67. 2% for ClearOne, Inc. (CLRO). Over 10 years, the gap is even starker: MTSI returned +795. 9% versus CLRO's -92. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), ClearOne, Inc.

(CLRO) is the lower-risk stock at 0. 93β versus Ambarella, Inc. 's 2. 53β — meaning AMBA is approximately 172% more volatile than CLRO relative to the S&P 500. On balance sheet safety, Ambarella, Inc. (AMBA) carries a lower debt/equity ratio of 1% versus 63% for Synaptics Incorporated — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), MACOM Technology Solutions Holdings, Inc.

(MTSI) is pulling ahead at 32. 6% versus -39. 1% for ClearOne, Inc. (CLRO). On earnings-per-share growth, the picture is similar: Ambarella, Inc. grew EPS 33. 2% year-over-year, compared to -1481. 2% for ClearOne, Inc.. Over a 3-year CAGR, MTSI leads at 12. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Synaptics Incorporated (SYNA) is the more profitable company, earning -4.

4% net margin versus -78. 9% for ClearOne, Inc. — meaning it keeps -4. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MTSI leads at 13. 4% versus -80. 9% for CLRO. At the gross margin level — before operating expenses — AMBA leads at 60. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, ClearOne, Inc.

(CLRO) trades at 21. 1x forward P/E versus 95. 4x for Ambarella, Inc. — 74. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AMBA: 32. 4% to $98. 33.

In this comparison, CLRO (19.

1% yield) pays a dividend. SYNA, MTSI, AMBA do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, ClearOne, Inc.

(CLRO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 93), 19. 1% yield). Synaptics Incorporated (SYNA) carries a higher beta of 2. 28 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CLRO: -92. 5%, SYNA: +60. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: CLRO is a small-cap income-oriented stock; SYNA is a small-cap quality compounder stock; MTSI is a mid-cap high-growth stock; AMBA is a small-cap high-growth stock. CLRO pays a dividend while SYNA, MTSI, AMBA do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.